Tech Company Financing Transactions

Satori Pharmaceuticals Funding Round

Satori Pharmaceuticals, operating out of Cambridge, raised $22 million from New Enterprise Associates, InterWest Partners and Prospect Venture Partners.

Transaction Overview

Company Information

Company Status

Out of Business

Industry

Biopharmaceutical

Mailing Address

281 Albany Street
Cambridge, MA 02139
USA

Phone

(617) 547-0022

Website

www.satoripharma.com

Email Address

[email protected]

Overview

Satori Pharmaceuticals is a neuroscience company focused on the discovery and development of innovative disease-modifying therapies for Alzheimer's disease, Parkinson's disease and other neurodegenerative disorders.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Jeffrey Ives

        

VP - R & D

Brian Bronk

        

VP - R & D

Barbara Tate

        

Browse more venture capital transactions:

Prev: 1/8/2009: Natera venture capital transaction
Next: 1/8/2009: Superprotonic venture capital transaction

Share this article

Where The Data Comes From

We do our best to report on funding rounds that are announced publicly. VC transactions reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary